El Salvador vs Guatemala: Number of deaths from cardiovascular diseases by type
El Salvador
16.8 deaths
in 2021
Guatemala
20.35 deaths
in 2021
El Salvador rank
150th
Guatemala rank
148th
Number of deaths from cardiovascular diseases by type over time
- El Salvador
- Guatemala
How they compare
Guatemala currently reports 20.35 deaths against 16.8 deaths in El Salvador, a difference of 3.55 deaths.
That makes Guatemala's figure about 1.2 times El Salvador's.
Across all 22 years both countries report, Guatemala has been ahead every year.
El Salvador ranks 150th and Guatemala ranks 148th of 194 countries.
Guatemala has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.81 deaths | 33.78 deaths | 12.96 deaths | Guatemala |
| 2010s | 17.41 deaths | 23.61 deaths | 6.2 deaths | Guatemala |
| 2020s | 16.7 deaths | 21.04 deaths | 4.34 deaths | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, El Salvador or Guatemala?
- Guatemala, at 20.35 deaths against 16.8 deaths in El Salvador as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between El Salvador and Guatemala?
- 3.55 deaths, with Guatemala ahead.
- How many years of comparable data are there for El Salvador and Guatemala?
- 22 years are reported by both, from 2000 to 2021.
- How do El Salvador and Guatemala rank globally for number of deaths from cardiovascular diseases by type?
- El Salvador ranks 150th and Guatemala ranks 148th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.